September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Patient-reported visual function in central serous retinopathy
Author Affiliations & Notes
  • Tin Yan Alvin Liu
    Wilmer Eye Institute, Baltimore, Maryland, United States
  • Pooja Mehta
    Wilmer Eye Institute, Baltimore, Maryland, United States
  • Neil M Bressler
    Wilmer Eye Institute, Baltimore, Maryland, United States
  • Footnotes
    Commercial Relationships   Tin Yan Liu, None; Pooja Mehta, None; Neil Bressler, None
  • Footnotes
    Support  Wilmer Research Grant 2015-2016
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 5607. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Tin Yan Alvin Liu, Pooja Mehta, Neil M Bressler; Patient-reported visual function in central serous retinopathy. Invest. Ophthalmol. Vis. Sci. 2016;57(12):5607.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose : Since there is little information on patient-reported vision function in central serous retinopathy (CSR), also termed central serous chorioretinopathy, and since these patients have been reported to complain about vision function out of proportion to their visual acuity, this study evaluated patient-reported visual function using the NEI-VFQ-25 questionnaire as well as the Hospital Anxiety and Depression Scale in patients with CSR.

Methods : In a cross-sectional prospective study following IRB approval, patients with CSR using ICD-9 codes were identified from the practice of one of the authors (NMB). Patients with other visual co-morbidities such as visually relevant cataract or whose diagnosis of CSR could not be confirmed on fundus imaging were excluded. Potentially eligible patients were contacted and the NEI-VFQ-25 questionnaire and Hospital Anxiety and Depression Scale (HADS) questionnaire were conducted over the phone after consent was obtained.

Results : Among 16 participants, the median age was 70 years and the time between the last clinic visit and the time of interview was a median of 1.44 years (range: 0-9.79 years), including 11 with bilateral involvement. Median logMAR (approximate Snellen equivalent) visual acuity in the better-seeing eye was 0.097 (20/25); the 25th percentile was 0 (20/20); the 75th percentile was 0.204 (20/32). Median (25th, 75th percentiles) NEI-VFQ-25 composite score was 87.1 (74.0, 93.4). The median score for “near activities” and “distance activities” subscales, respectively, were 79.2 and 87.5. The median (25th, 75th percentile) HADS anxiety was 3.5 (2.8, 6.3) including 1 who scored 8 to 10 (doubtful) and 1 who scored 11 or more (definite), while HADS depression was 1.5 (1, 4.3) including 2 who scored 8 to 10 (doubtful).

Conclusions : These data suggest that CSR patients have fairly preserved visual function, although anxiety or depression may be doubtful or definite in some. The relatively small numbers suggests fairly wide confidence intervals around these point estimate results.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.